XML 53 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 8,302,290 $ 10,819,781
Accounts receivable 56,501 168,381
Prepaid expenses and other assets 164,716 60,041
Total current assets 8,523,507 11,048,203
Property and equipment, net 570,947 254,742
Other assets 530,612 362,081
Total assets 9,625,066 11,665,026
Current liabilities:    
Accounts payable 297,825 175,679
Accrued expenses 1,101,412 554,691
Current portion of long-term debt 62,993  
Total current liabilities 1,462,230 730,370
Long-term debt, less current portion 252,175  
Derivative financial instruments 10,381,796 8,765,628
Total liabilities 12,096,201 9,495,998
Commitments and contingencies (Note 9)      
Stockholders' (deficiency) equity:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized, 78,100 and 95,600 shares outstanding at June 30, 2013 and December 31, 2012, respectively, designated as Series A Convertible Preferred Stock with liquidation preference of $780,100 and $956,000 at June 30, 2013 and December 31, 2012, respectively 78 96
Common stock, $0.0001 par value, 150,000,000 shares authorized, 15,729,524 and 15,478,177 issued and outstanding at June 30, 2013 and December 31, 2012, respectively 1,573 1,547
Additional paid-in capital 59,125,903 57,370,017
Deficit accumulated during development stage (61,598,689) (55,202,632)
Total stockholders' (deficiency) equity (2,471,135) 2,169,028
Total liabilities and stockholders' (deficiency) equity $ 9,625,066 $ 11,665,026